
HUB Organoids
Utrecht, Netherlands huborganoids.nl From their website, Nov 2026
Work here? Claim this listing
About
HUB Organoids develops patient-derived organoid technology and offers preclinical drug discovery and co-clinical testing services for pharmaceutical and biotech customers. It supports work in oncology, immuno-oncology, inflammatory diseases, genetic diseases, infectious diseases, toxicology, and metabolic disease from its operations in the Netherlands.
Services
Drug screening services
Uses patient-derived organoids to evaluate compound efficacy and toxicity and predict patient-specific responses in preclinical drug development.
Custom model and assay development
Develops new disease models, organoid co-cultures, biomarkers, functional assays, and advanced imaging readouts tailored to client needs.
Clinical trials in a dish
Tests clinical candidates in patient-derived organoids from trial participants to predict response, stratify responders and non-responders, and discover biomarkers.
PDO Screen
A preset screening panel of patient-derived tumor organoids for fast, cost-efficient evaluation of oncology agents.
PDO Co-cultures
Organoid-based immune cell co-culture systems for evaluating drug effects on epithelium, immune cells, and stromal cells in oncology and inflammatory disease models.
ADC Organoid Screen
Tests antibody-drug conjugates in patient-derived organoid models and matched normal organoids to assess efficacy and off-tumor toxicity.
KRAS Inhibitor Testing
Provides patient-derived organoid screening and resistance models for evaluating KRAS-targeted compounds and acquired resistance.
IntegriGut Screen
Screens compounds in inflammatory disease models to assess protective effects against epithelial damage.
8 more services
- HumanTox Insight
- Liver toxicity screening
- Organoid-based GI toxicology platform
- Organoid and T cell co-culture toxicity testing
- License program
- KRAS Inhibitor Testing Solutions
- mCRC PDO Screening Panel
- Bispecific Screening Solutions
- What to send
- Patient tissue biopsies
- Patient-derived tumor tissue
- Intestinal crypt biopsies
- Airway, intestinal, liver, or kidney biopsies
Capabilities
- Assays and studies
- Toxicology
- In vivo
- ADCs
- Antibodies
- Bispecifics
- Rodent models
17 more
- Drug screening
- Efficacy testing
- Toxicity testing
- Co-culture assays
- Barrier integrity assays
- Cytokine profiling
- Viral replication analysis
- Live-cell imaging
- Flow cytometry
- ATP-based viability assay
- Monolayer infection assays
- Biomarker discovery
- Custom assay development
- Tumor-immune interaction assays
- Predictive toxicology
- Resistance mechanism studies
- Clinical trials in a dish
- Scale and capacity
- Bladder cancer biobank comprising more than 50 patient-derived organoid models
- KRASmut PDO Biobank with over 50 PDOs
- KRASmut PDO Screen using 25 patient-derived organoids
- Thousands of patient-derived organoids across multiple tissue types and disease indications
- Therapeutic areas
- Oncology
- Immuno-oncology
- Inflammatory diseases
- Genetic diseases
- Infectious diseases
- Toxicology
- Metabolic disease
Instruments and platforms
- Flow cytometry
- Live-cell imaging
Modalities and species
- Modalities
- Small molecule
- Antibody
- Bispecific
- ADC
- Cell therapy
- Species and models
- Patient-derived tumor organoids
- Patient-derived normal organoids
- Human airway organoid monolayers
- Human intestinal organoids
- Human liver organoids
- Human kidney organoids
13 more
- PBMCs
- TILs
- T cells
- Macrophages
- Fibroblasts
- Neutrophils
- NK cells
- Bacteria
- Viruses
- Human patient-derived organoids
- Adult stem cell–derived organoids
- Mouse intestine organoid
- Human intestinal epithelium organoid
Industries served
- Drug discovery
- Drug development
Company
- Type
- CRO
- Founded
- 2023
- Quality
- Research use only · DNA- and RNA-seq analysis (quality control and characterization of organoid models)
Locations
- Based in
- Utrecht, Netherlands
- Sites
- Darmstadt, Germany
- Serves
- Global
Contacts
- General enquiry
- info@huborganoids.nl on their site
- Phone
- +31 (0)88 12 36 300